Completed
An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy
NCT03921528
- Conditions
- Atrophy, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +19 more
- Locations
-
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Stanford University Palo Alto, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- The Johns Hopkins University Baltimore, Maryland, United States